ACCORD Trial Complicates “Treating To New Targets” Theory In Diabetes
Executive Summary
The large government-sponsored ACCORD trial in type 2 diabetes has stumbled in trying to show that driving down blood glucose to normal levels can improve cardiovascular outcomes in high-risk patients